Newrotex Ltd
Newrotex is a UK-based biotech firm developing innovative silk-based medical solutions for nerve repair and the nervous system. Their mission is to disrupt existing approaches to surgical nerve repair by providing off-the-shelf, effective, and low-cost silk conduit solutions, aiming to improve patient outcomes and reduce surgical times and costs.
Industries
Nr. of Employees
small (1-50)
Patents
Bridging peripheral nerve gaps with conduits for enhanced nerve regeneration
US-12544073-B2
View DetailsBridging peripheral nerve gaps with conduits for enhanced nerve regeneration
US-12471923-B2
View DetailsBridging peripheral nerve gaps with conduits for enhanced nerve regeneration
US-11602348-B2
View Details
Bridging peripheral nerve gaps with conduits for enhanced nerve regeneration
US-12544073-B2
View DetailsBridging peripheral nerve gaps with conduits for enhanced nerve regeneration
US-12471923-B2
View DetailsBridging peripheral nerve gaps with conduits for enhanced nerve regeneration
US-11602348-B2
View DetailsProducts
The Oxford Nerve Conduit
A silk-based peripheral nerve conduit filled with luminal silk fibres, designed to guide nerve regeneration and encourage vascularisation. It is available in various lengths and diameters, and animal trials show it to be comparable or superior to autografts.
The Oxford Nerve Conduit
A silk-based peripheral nerve conduit filled with luminal silk fibres, designed to guide nerve regeneration and encourage vascularisation. It is available in various lengths and diameters, and animal trials show it to be comparable or superior to autografts.
News & Updates
Dr Alex Woods (CEO) attended the US MedTech Innovator Road Tour in Baltimore, selected from over 1100 companies to present to industry leaders, investors, and medical experts.
Researchers from MedUni Vienna and Professor Fritz Vollrath published an article in Advanced Healthcare Materials demonstrating the regenerative properties of silk fibres from spiders and moths for bridging nerve defects.
Newrotex was selected as a top startup at the ASPS Plastic Surgery Accelerator, receiving positive feedback and forming new collaborations.
Newrotex was chosen from over 1,150 applicants to join the world's largest MedTech accelerator, recognizing the potential of their silk technology for nerve injury treatment.
Interview with Newrotex founders Dr. Alex Woods and Professor Fritz Vollrath discussing the uses of silk in nerve repair and their innovative work.
Alex Woods, CEO of Newrotex, will give an invited talk at the Oxford Surgical Innovation Conference at St Catherine’s College, Oxford.
Dr Alex Woods (CEO) attended the US MedTech Innovator Road Tour in Baltimore, selected from over 1100 companies to present to industry leaders, investors, and medical experts.
Researchers from MedUni Vienna and Professor Fritz Vollrath published an article in Advanced Healthcare Materials demonstrating the regenerative properties of silk fibres from spiders and moths for bridging nerve defects.
Newrotex was selected as a top startup at the ASPS Plastic Surgery Accelerator, receiving positive feedback and forming new collaborations.
Newrotex was chosen from over 1,150 applicants to join the world's largest MedTech accelerator, recognizing the potential of their silk technology for nerve injury treatment.
Interview with Newrotex founders Dr. Alex Woods and Professor Fritz Vollrath discussing the uses of silk in nerve repair and their innovative work.
Alex Woods, CEO of Newrotex, will give an invited talk at the Oxford Surgical Innovation Conference at St Catherine’s College, Oxford.